Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Prog Urol ; 27(16): 1058-1067, 2017 Dec.
Artigo em Francês | MEDLINE | ID: mdl-29102377

RESUMO

OBJECTIVE: In Morocco, as in many countries, a large number of patients use medicinal plants to treat their disease including urinary lithiasis. The aim of the present work is to study the antilithiasic effect of Erica multiflora aqueous extract, purported for its antilithiasic effect in the oriental region of Morocco. METHODS: E. multiflora aqueous extract was studied in two oxalo-calcic models of rats rendered experimentally lithiasic. Urinary biochemistry parameters were measured and histological slides of kidneys were analyzed. The effect of the extract was also tested in a magnesium ammonium phosphate crystallization model in vitro. The number of crystals and their size in presence and absence of extract were compared. RESULTS: E. multiflora extract did not inhibit the development of parenchymal and papillary calcifications and therefore did not prevent calcium oxalate crystallization into kidneys. Even if there was an increase in urinary pH and diuresis, the plant extract did not show a significant inhibitory activity against calcium oxalate crystallization. However, the plant extract exerted an efficient antilithiasic activity toward struvite crystallization inhibiting the formation of crystals by reduction of their size and numbers as well as their aggregation. CONCLUSION: E. multiflora aqueous extract need to be used in the inhibition and elimination of magnesium ammonium phosphate crystals rather than calcium oxalate ones. LEVEL OF EVIDENCE: 3.


Assuntos
Oxalato de Cálcio , Ericaceae , Fitoterapia , Extratos Vegetais/uso terapêutico , Estruvita , Urolitíase/prevenção & controle , Animais , Masculino , Ratos , Ratos Wistar
2.
Urol Res ; 37(2): 75-82, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19183977

RESUMO

Cynodon dactylon (Poaceae family) decoction was used in the treatment of kidney stones. However, no scientific study was undertaken so far to demonstrate the beneficial effect of the plant. Thus, the aim of the current study is to evaluate the effect of Cynodon aqueous extract as a preventive and curative agent in experimentally induced nephrolithiasis in a rat model. Ethylene glycol (EG) was used in the experiment to induce calcium oxalate (CaOx) deposition into kidneys. In preventive protocol, Cynodon decoction was administered in the same day with EG to evaluate the ability of the extract to prevent crystal deposition. However, in curative protocol, rats were first rendered nephrolithiasic and then the extract was administered to assess the ability of the plant to eliminate the pre-existing crystal deposition. In both protocols, urinary biochemical and other variables were measured during the course of the study. Crystalluria and renal histology were examined as well. The results showed that, in both protocols, all measured variables were similar for both the rat groups. Nevertheless, urinary biochemical analysis was apparently unaffected by the extract except oxalate in preventive protocol, and calcium, sodium, and potassium in curative protocol which were significantly highly excreted in treated rats compared to untreated animals. Crystalluria was characterized mostly by the presence of large quantities of CaOx monohydrate and CaOx dihydrate particles in untreated rats. However, crystalluria was mainly dominated by the presence of CaOx dihydrate particles with reduced size. The most apparent beneficial effect of Cynodon extract was seen in kidney tissues where reduced levels of CaOx deposition have been noticed especially in medullary and papillary sections from treated rats. We concluded that C. dactylon extract has beneficial effect in preventing and eliminating CaOx deposition into kidneys. Such findings provide a scientific explanation for its use in the treatment of kidneys stones.


Assuntos
Cynodon , Nefrolitíase/tratamento farmacológico , Nefrolitíase/prevenção & controle , Fitoterapia , Animais , Oxalato de Cálcio/química , Oxalato de Cálcio/metabolismo , Oxalato de Cálcio/urina , Cristalização , Modelos Animais de Doenças , Etilenoglicol/toxicidade , Rim/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , Masculino , Nefrolitíase/induzido quimicamente , Nefrolitíase/metabolismo , Extratos Vegetais/uso terapêutico , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...